2004Journal of Pediatric PharmacyRequires access

28 case reports of surfactant therapy (Curosurt) in neonates with meconium aspiration syndrome

Chen Yin-bin

Open publisher page 0 citations

Abstract

Objective: To study the efficacy of pulmonary surfactant (PS) in the newborn infants with severe meconium aspiration syndrome(MAS). Methods: 28 infants with severe MAS were randomly divided into two groups. The treatment group (13 cases) were treated with PS, control group (15 cases) were treated in usually way. Results: The mean oxygenation index (OI) of the PS group decreased from 21.5±4.6 to 12.8±1.6,which was significantly lower compared with control group (P 0.05); arterial/alveolar oxygen tension ratio (a/APO2) of the PS group increased form 0.10±0.04 to 0.31±0.05, which was significantly higher compared with control group (P 0.05). The durations of mechanical, oxygen therapy, and admission were significantly short in the PS group than in control group. Conclusion: PS therapy may result in a rapid improvement in oxygenation, and reduce the duration of mechanical ventilation and hospitalization time of newborn infants with severe MAS.

About this research paper

What this paper is about

Objective: To study the efficacy of pulmonary surfactant (PS) in the newborn infants with severe meconium aspiration syndrome(MAS). Methods: 28 infants with severe MAS were randomly divided into two groups. The treatment group (13 cases) were treated with PS, control group (15 cases) were treated in usually way. Results: The mean oxygenation index (OI) of the PS group decreased from 21.5±4.6 to 12.8±1.6,which was significantly lower compared with control group (P 0.05); arterial/alveolar oxygen tension ratio (a/APO2) of the PS group increased form 0.10±0.04 to 0.31±0.05, which was significantly higher compared with control group (P 0.05). The durations of mechanical, oxygen therapy, and admission were significantly short in the PS group than in control group. Conclusion: PS therapy may result in a rapid improvement in oxygenation, and reduce the duration of mechanical ventilation and hospitalization time of newborn infants with severe MAS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the efficacy of pulmonary surfactant (PS) in the newborn infants with severe meconium aspiration syndrome(MAS). Methods: 28 infants with severe MAS were randomly divided into two groups. The treatment group (13 cases) were treated with PS, control group (15 cases) were treated in usually way. Results: The mean oxygenation index (OI) of the PS group decreased from 21.5±4.6 to 12.8±1.6,which was significantly lower compared with control group (P 0.05); arterial/alveolar oxygen tension ratio (a/APO2) of the PS group increased form 0.10±0.04 to 0.31±0.05, which was significantly higher compared with control group (P 0.05). The durations of mechanical, oxygen therapy, and admission were significantly short in the PS group than in control group. Conclusion: PS therapy may result in a rapid improvement in oxygenation, and reduce the duration of mechanical ventilation and hospitalization time of newborn infants with severe MAS.

Key concepts: Meconium aspiration syndrome, Medicine, Oxygenation index, Mechanical ventilation, Oxygenation, Pulmonary surfactant, Meconium, Oxygen therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
28 case reports of surfactant therapy (Curosurt) in neonates with meconium aspiration syndrome — Research Paper | ScholarLens